Samchundang Pharmaceutical "Suspends Negotiations on 300 Billion KRW Investment with Global Pharma for Vaccine Development"

[Asia Economy Reporter Minji Lee] Samchundang Pharmaceutical announced on the 2nd that it had been in talks with a global pharmaceutical company in May last year to invest 300 billion KRW in developing the world's best oral COVID-19 vaccine. However, considering the demand and growth potential of the COVID vaccine market, the overseas partner informed them that continued development would be difficult, leading to the decision to halt the negotiations.